Worldwide News

First European Commission COVID-19 vaccine agreement enables all EU member states to access the vaccine at no profit during the pandemic. AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine. Building on the existing agreement with Europe’s Inclusive Vaccines Alliance spearheaded by […]

George Washington University researchers analysed five biomarkers present in the blood of hundreds of COVID-19 patients, finding elevated levels associated with higher odds of clinical deterioration and death. “When we first started treating COVID-19 patients, we watched them get better or get worse, but we didn’t know why,” said Juan Reyes, MD, co-author of the […]

UK government to purchase 60 million doses of NVX-CoV2373. Novavax, a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, has signed a deal with the UK government for the purchase of 60 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine, and a Phase 3 clinical trial to assess the efficacy of the vaccine […]

13 August 2020 Image: Ana Auza Bone Therapeutics has been granted EUR1 million from the Directorate-General for Economy, Employment and Research of the Walloon Region, Belgium. This funding will provide further financial support to Bone Therapeutics, in addition to recent financing, to advance its current pivotal phase III clinical study with the enriched protein solution, […]

13 August 2020 Image: Edward Cisneros A non-hormonal therapy to treat hot flashes and other symptoms associated with menopause was found to be effective in a recent clinical trial. This is according to a published study by a team of researchers including faculty from the University of Colorado School of Medicine. Fezolinetant, an oral, non-hormone […]

This year’s Analytica will be available in two formats – physical and digital. Organisers of the event for laboratory technology, analysis and biotechnology will also run Analytica Virtual to enable exhibitors and visitors who cannot come to Munich due to travel restrictions to participate. Analytica Virtual will run alongside the classic Analytica in Munich (October 19 to […]

Collaboration to develop stem cell therapies for COVID-19 and future pandemic diseases. Avacta has announced an expansion of its collaboratin with Daewoong Pharmaceutical Co and AffyXell Therapeutics are to to develop stem cell treatments incorporating Avacta’s neutralising Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop […]

The experimental drug has shown promise in early-stage clinical trials conducted in Singapore, by Anne Trafton, MIT News Office. Yellow fever, a haemorrhagic disease that is common in South America and sub-Saharan Africa, infects about 200,000 people per year and causes an estimated 30,000 deaths. While there is a vaccine for yellow fever, it can’t […]

Stanford chemists have developed a new tool that shuttles unwanted cell surface proteins to their deaths, by Rebecca McClellan When scientists find a potentially dangerous protein on a cell, they might imagine shrinking themselves down to become tiny surgeons, cutting out just the problematic molecule and leaving the healthy parts of the cell intact. While […]

Ligandal has announced positive results of lab studies that indicate the likelihood of the synthetic peptide, SARS-BLOCK, becoming an effective combination treatment and vaccine to COVID-19. The experiments, in conjunction with the Stroud Lab, University of California San Francisco, demonstrate SARS-BLOCK halts infection of SARS-CoV-2. In addition to being an effective inhibitor of infection in […]